Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyi Jian

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Communications|January 3, 2025
Structural basis of human VANGL-PRICKLE interactionYanyi Song, Shuyi Jian, Junlin Teng, et al.
Frontiers in Oncology|May 5, 2023
Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancerBin Tang, Min Wu, Lin Zhang, et al.
Cancer Letters|February 5, 2022
A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growthHuang Chen, Ying Miao, Aiwu Bian, et al.
Brain Research Bulletin|December 17, 2023
Discriminative analysis of schizophrenia patients using an integrated model combining 3D CNN with 2D CNN: A multimodal MR image and connectomics analysisHaiman Guo, Shuyi Jian, Yubin Zhou, et al.
Genes & Diseases|August 18, 2025
Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastomaMin Wu, Lin Zhang, Weikai Guo, et al.
International Journal of Biological Sciences|January 3, 2024
Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancerMin Wu, Jiuqing Xie, Yajing Xing, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Communications|January 3, 2025
Structural basis of human VANGL-PRICKLE interactionYanyi Song, Shuyi Jian, Junlin Teng, et al.
Frontiers in Oncology|May 5, 2023
Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancerBin Tang, Min Wu, Lin Zhang, et al.
Cancer Letters|February 5, 2022
A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growthHuang Chen, Ying Miao, Aiwu Bian, et al.
Brain Research Bulletin|December 17, 2023
Discriminative analysis of schizophrenia patients using an integrated model combining 3D CNN with 2D CNN: A multimodal MR image and connectomics analysisHaiman Guo, Shuyi Jian, Yubin Zhou, et al.
Genes & Diseases|August 18, 2025
Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastomaMin Wu, Lin Zhang, Weikai Guo, et al.
International Journal of Biological Sciences|January 3, 2024
Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancerMin Wu, Jiuqing Xie, Yajing Xing, et al.
Pageof 1